Work

Data from Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy?

Year: 2023

Type: other

Abstract: Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient care and may provide leads in the development of early detection strategies.

DOI: 10.1158/1078-0432.c.6517143.v1

Authors: Ronny Drapkin, Adam Clauss, Steven Skates

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361948626

Cites:

Cited by:

Related to: 10